<DOC>
	<DOC>NCT01262690</DOC>
	<brief_summary>This study will examine whether a single dose of PF-05230901 is safe and well tolerated when given to healthy volunteers by injection under the skin. An additional objective is to measure the blood concentrations of PF-05230901. Each dose will be tested in a different group of subjects starting from the lowest dose.</brief_summary>
	<brief_title>A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin</brief_title>
	<detailed_description />
	<mesh_term>Cachexia</mesh_term>
	<criteria>Healthy subjects History of seizures, including childhood seizures. History of movement disorders or related neurological conditions. History of head trauma associated with loss of consciousness.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>First-in-human (FIH)</keyword>
	<keyword>Single Ascending Dose (SAD) Study</keyword>
	<keyword>TAM-163</keyword>
	<keyword>PF-05230901</keyword>
	<keyword>Cachexia</keyword>
</DOC>